Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry
Research output: Contribution to journal › Letter › Research › peer-review
Original language | English |
---|---|
Journal | Annals of the Rheumatic Diseases |
Volume | 75 |
Issue number | 4 |
Pages (from-to) | 785-6 |
Number of pages | 2 |
ISSN | 0003-4967 |
DOIs | |
Publication status | Published - Apr 2016 |
- Adult, Aged, Antirheumatic Agents, Arthritis, Psoriatic, Arthritis, Rheumatoid, Denmark, Female, Humans, Incidence, Male, Middle Aged, Multiple Sclerosis, Registries, Risk Factors, Spondylitis, Ankylosing, Tumor Necrosis Factor-alpha, Letter, Research Support, Non-U.S. Gov't
Research areas
ID: 164533422